From Almaty to Stanford: Freedom Holding becomes a global business case study
The case, titled 'Freedom Holding: Building an Ecosystem as a Path to Scale,' explores the transformation of a small brokerage firm into a digital ecosystem that today unites finance, insurance, payment solutions, telecommunications, and everyday online services. The company's central platform, the Freedom SuperApp, allows users to manage both their finances and daily lives in a single digital space.
'If you don't give the customer everything in one place, they'll go somewhere more convenient. We weren't just building a product — we were building an environment where people enjoy living,' said Timur Turlov, CEO of Freedom Holding. The story of Freedom Holding is not just a success story — it's described as 'a guide to survival and scaling in times of uncertainty.'
Key themes explored in the study include:
• Leading in the absence of formal rules
• Building infrastructure from scratch
• Growth through service integration
• Strategic balance between competition and cooperation
• The role of mission and values in strategic decision-making
Today, Freedom Holding is considering multiple paths for future development — from strengthening its position in Kazakhstan to entering new markets in the Middle East, Southeast Asia, and Africa.
The case was developed jointly by Stanford faculty and representatives of Freedom Holding, and is already being used in Stanford's course on platform strategy and digital transformation in emerging markets.
'This is a moment of pride not only for our team, but for the entire region. We've proven that big ideas can be born outside of New York and London — in places like Almaty or Astana,' Turlov said.
About Freedom Holding Corp.
Freedom Holding Corp. is an international financial and technology group listed on the Nasdaq (ticker: FRHC). The company offers investment, banking, insurance, and digital services through its integrated platform, Freedom SuperApp. The group operates in 22 countries, including Kazakhstan, the United States, Cyprus, Poland, Spain, Uzbekistan, and Armenia. The Company's principal executive office is located in New York City. Freedom Holding Corp. is regulated by the U.S. Securities and Exchange Commission (SEC).Natalia KharlashinaFreedom Holding Corp.prglobal@ffin.kz+77013641454Permalink | © Copyright 2025 etf.com. All rights reserved
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Earnings To Watch: Assurant (AIZ) Reports Q2 Results Tomorrow
Insurance services company Assurant (NYSE:AIZ) will be reporting results this Tuesday afternoon. Here's what investors should know. Assurant met analysts' revenue expectations last quarter, reporting revenues of $3.07 billion, up 6.7% year on year. It was a strong quarter for the company, with a solid beat of analysts' EPS estimates and an impressive beat of analysts' net premiums earned estimates. Is Assurant a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Assurant's revenue to grow 6.5% year on year to $3.11 billion, in line with the 7.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $4.45 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Assurant has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 2% on average. Looking at Assurant's peers in the property & casualty insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Mercury General delivered year-on-year revenue growth of 13.2%, beating analysts' expectations by 2%, and Allstate reported revenues up 6%, falling short of estimates by 0.7%. Mercury General's stock price was unchanged after the resultswhile Allstate was up 5.7%. Read our full analysis of Mercury General's results here and Allstate's results here. The euphoria surrounding Trump's November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the property & casualty insurance stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4% on average over the last month. Assurant is down 2.6% during the same time and is heading into earnings with an average analyst price target of $233.20 (compared to the current share price of $186.48). Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
25 minutes ago
- Bloomberg
China to Tax Bond Interest Income After Decades of Exemption
China said it plans to tax interest income on bonds issued by the government and financial institutions, in a surprise move that's prompted investors to reevaluate their debt market positions. The government will resume collection of value-added tax on interest income from bonds sold by central and local governments, as well as those from financial institutions starting Aug. 8, the Ministry of Finance said in a statement released on Friday. Bonds issued before that, including the reopening sales on these notes, will be exempted from the tax.
Yahoo
37 minutes ago
- Yahoo
Amneal Earnings: What To Look For From AMRX
Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) will be reporting earnings this Tuesday before the bell. Here's what investors should know. Amneal missed analysts' revenue expectations by 3.4% last quarter, reporting revenues of $695.4 million, up 5.5% year on year. It was a mixed quarter for the company, with an impressive beat of analysts' EPS estimates but a slight miss of analysts' full-year EPS guidance estimates. Is Amneal a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Amneal's revenue to grow 5.8% year on year to $742.8 million, slowing from the 17.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.17 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Amneal has missed Wall Street's revenue estimates three times over the last two years. Looking at Amneal's peers in the pharmaceuticals segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Bristol-Myers Squibb posted flat year-on-year revenue, beating analysts' expectations by 7.8%, and Merck reported a revenue decline of 1.9%, falling short of estimates by 1.1%. Bristol-Myers Squibb traded down 3.9% following the results while Merck was also down 2.7%. Read our full analysis of Bristol-Myers Squibb's results here and Merck's results here. The euphoria surrounding Trump's November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the pharmaceuticals stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. Amneal is down 5.1% during the same time and is heading into earnings with an average analyst price target of $11.75 (compared to the current share price of $7.98). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
